Recent research links AstraZeneca's Covishield vaccine to another rare blood disorder, Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT). Autoantibodies targeting platelet factor 4 (PF4) are identified as the culprit. This discovery adds to existing concerns regarding the vaccine's safety profile. Scientists stress the importance of continued monitoring and investigation into potential adverse effects. The findings underscore the complexity of vaccine-related complications and highlight the necessity of thorough safety evaluations in vaccine development and administration.

A waterborne disease outbreak has struck South West England, with at least 22 confirmed cases prompting urgent measures. Residents in affected areas, including Alston and the Hillhead area of Brixham in Devon, have been advised to boil their tap water after traces of the parasite cryptosporidium were found. South West Water, in collaboration with the UK Health Security Agency, is working to identify and eliminate the source of the contamination. Symptomatic individuals are urged to seek medical advice, while the community braces for potential further cases. Investigation and precautionary measures continue amidst public concern.            

The Indian Council of Medical Research (ICMR) warns against consuming tea or coffee one hour before and after meals. Caffeine in these beverages can interfere with iron absorption due to tannin content, affecting haemoglobin production and energy levels. ICMR advises moderation in caffeine intake, limiting it to 300mg/day. Tea without milk is suggested for promoting blood circulation and reducing the risk of coronary artery disease. Additionally, excessive coffee consumption is linked to high blood pressure. Other guidelines emphasize a balanced diet rich in fruits, vegetables, and lean meats, while avoiding protein supplements and excessive oil, sugar, and salt.

Brianne Dressen, 42, files a lawsuit against AstraZeneca in Utah, claiming she became "permanently disabled" after participating in the US clinical trial of its COVID-19 vaccine. Dressen alleges AstraZeneca failed to cover her medical expenses for severe neurological side effects, leading to a diagnosis of post-vaccine neuropathy. Despite facing thousands in medical bills, Dressen refused a small payout from AstraZeneca. The lawsuit follows AstraZeneca's admission of rare side effects in its vaccine, prompting over 50 class action lawsuits in the UK and a global withdrawal request due to commercial reasons. AstraZeneca is yet to comment.      

Mosquitoes, including disease-carrying types, have been discovered across Scotland for the first time by University of Glasgow researchers amidst rising temperatures. The presence of 16 mosquito varieties raises concerns over increased populations and disease transmission due to climate change. Public Health Scotland stresses the importance of surveillance and early detection systems, especially with the potential invasion of invasive species like the Asian tiger mosquito. Experts warn of warmer winters aiding mosquito survival and expansion. Urgent government-backed studies are needed to assess and mitigate risks. The UK Health Security Agency implements surveillance networks to monitor mosquito presence and prevent disease outbreaks.  

Five infants have died of whooping cough in the UK this year, with over 2,700 cases reported. UK Health Security Agency attributes rise to reduced immunity due to COVID-19 pandemic. Babies under three months most vulnerable; 50.8% of cases in 15+ age group. Vaccine effectiveness in pregnancy estimated at 92%, emphasizing importance of timely vaccinations. Calls for increased vaccination uptake amid decline in recent years. NHS urges families to seek protection, emphasizing severity of disease in young infants. Health officials stress need for rapid action to prevent further deaths and boost vaccine uptake.

In a groundbreaking development, 18-month-old Opal Sandy from Oxfordshire hears almost perfectly after receiving pioneering gene therapy for auditory neuropathy. The procedure, which took just 16 minutes, marks a new era in treating deafness. Doctors at Addenbrooke’s hospital, Cambridge, are running the Chord trial, recruiting deaf children from the UK, Spain, and the US. Prof. Manohar Bance, the trial's chief investigator, expresses optimism, stating the results are better than expected. The therapy, using a working copy of the OTOF gene, is a potential cure. Opal is the first patient globally to undergo this treatment, offering hope for others.

Parents of deceased daughters plan to sue AstraZeneca after it admitted Covishield's rare side effects in UK court. Venugopalan Govindan criticizes Serum Institute for not stopping supply despite European restrictions. He promises legal action if justice isn't served. Rachana Gangu, another parent, requests a medical probe and compensation. AstraZeneca faces a UK lawsuit over alleged vaccine-related deaths and injuries, acknowledging rare clotting issues. Grieving parents demand accountability from vaccine makers and government authorities for vaccine approval.

A study presented at the ESCMID Global Congress reveals the presence of pathogenic bacteria and fungi, including multidrug-resistant "superbugs," on surfaces of UK hospital toilets. Led by Professor Stephanie Dancer, the research found patient toilets to be worst affected, posing significant health threats. Women's bathrooms exhibited fewer microbes than men's, attributed to gender disparities in hygiene habits. Gram-negative pathogens were found on various surfaces due to aerosolization during flushing. Recommendations include closing toilet lids before flushing and prioritizing hand hygiene education. The findings underscore the importance of improved hygiene practices in healthcare settings.

Former ICMR scientist Dr. Raman Gangakhedkar reassures that only 7 to 8 individuals out of 10 lakh vaccinated with Covishield face the rare side effect of thrombosis thrombocytopenia syndrome (TTS). He highlights that the risk is highest after the first dose but decreases with subsequent doses. Gangakhedkar emphasizes the vaccine's overall positive impact on millions, despite AstraZeneca's acknowledgment of rare blood clotting side effects. With at least 90% of Indians inoculated with Covishield, Gangakhedkar urges understanding of the minimal risk compared to the vaccine's widespread benefits.